newsfilter
← Latest News
GlobeNewswire·

LianBio Enters into Agreement with Bristol Myers Squibb for Mavacamten in China and Other Asian Markets

LianBio to receive total upfront consideration of $350 millionLianBio Board of Directors to conduct strategic review of business SHANGHAI and PRINCETON, N.J., Oct. 24, 2023 (GLOBE NEWSWIRE) -- LianBio (NASDAQ:LIAN),